Journal Article

Validation of the Cozart<sup>®</sup> Microplate EIA for Cocaine and Metabolites in Oral Fluid

Gail Cooper, Lisa Wilson, Claire Reid, Dene Baldwin, Chris Hand and Vina Spieher

in Journal of Analytical Toxicology

Volume 28, issue 6, pages 498-503
Published in print September 2004 | ISSN: 0146-4760
Published online September 2004 | e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/28.6.498
Validation of the Cozart® Microplate EIA for Cocaine and Metabolites in Oral Fluid

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

The purpose of these studies was to determine the performance characteristics of the Cozart microplate EIA for the detection of cocaine and cocaine metabolites in oral fluid. A total of 217 samples were collected using the Cozart RapiScan oral fluid Collection System from donors who were receiving treatment and being monitored for their addiction. The samples were screened in the laboratory using the Cozart microplate EIA for cocaine and metabolites and confirmed using gas chromatography-mass spectrometry (GC-MS). The samples were stored frozen until analysis by GC-MS. Of the 217 samples tested, 116 were positive for cocaine and/or cocaine metabolites. The Cozart microplate EIA for cocaine, using a cutoff of 30 ng/mL benzoylecgonine equivalents in neat oral fluid, had a sensitivity of 95.7% ± 2.0% and specificity of 100% ± 0.7%. A series of potential adulterants of oral fluid were evaluated and shown not to alter the outcome of the test result.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.